These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9234178)

  • 1. Positive selection and transplantation of peripheral CD34+ progenitor cells: feasibility and purging efficacy in pediatric patients with neuroblastoma.
    Handgretinger R; Greil J; Schürmann U; Lang P; Gonzalez-Ramella O; Schmidt I; Führer R; Niethammer D; Klingebiel T
    J Hematother; 1997 Jun; 6(3):235-42. PubMed ID: 9234178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and transplantation of highly purified autologous peripheral CD34(+) progenitor cells: purging efficacy, hematopoietic reconstitution and long-term outcome in children with high-risk neuroblastoma.
    Handgretinger R; Lang P; Ihm K; Schumm M; Geiselhart A; Koscielniak E; Hero B; Klingebiel T; Niethammer D
    Bone Marrow Transplant; 2002 May; 29(9):731-6. PubMed ID: 12040469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapy.
    Mohr M; Hilgenfeld E; Fietz T; Hoppe B; Koenigsmann M; Hoffmann M; Knauf WU; Cassens U; Sibrowski W; Kienast J; Thiel E; Berdel WE
    Clin Cancer Res; 1999 May; 5(5):1035-40. PubMed ID: 10353736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
    Lemoli RM; Cavo M; Fortuna A
    J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and transplantation of autologous peripheral CD34+ progenitor cells highly purified by magnetic-activated cell sorting.
    Handgretinger R; Lang P; Schumm M; Taylor G; Neu S; Koscielnak E; Niethammer D; Klingebiel T
    Bone Marrow Transplant; 1998 May; 21(10):987-93. PubMed ID: 9632271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular monitoring of tumor cell contamination in leukapheresis products from stage IV neuroblastoma patients before and after positive CD34 selection.
    Tchirkov A; Kanold J; Giollant M; Halle-Haus P; Berger M; Rapatel C; Lutz P; Bergeron C; Plantaz D; Vannier JP; Stephan JL; Favrot M; Bordigoni P; Malet P; Briançon G; Deméocq F
    Med Pediatr Oncol; 1998 Apr; 30(4):228-32. PubMed ID: 9473757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.
    Leong CF; Habsah A; Teh HS; Goh KY; Fadilah SA; Cheong SK
    Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Autologous transplantation of hematopoietic precursor cells following CD34 selection].
    Tichelli A; Gratwohl A; Bargetzi M; Nissen C; Wernli M; Herrmann R; Orth B; Signer E; Speck B
    Schweiz Med Wochenschr; 1996 Feb; 126(6):201-6. PubMed ID: 8720723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
    Kasow KA; Sims-Poston L; Eldridge P; Hale GA
    Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of a PB CD34+ cell transplantation procedure using standard leukapheresis products in very small children.
    Berger M; Kanold J; Rapatel C; deLumley L; Lutz P; Plantaz D; Vannier JP; Mechinaud F; Bergeron C; Favrot M; Gembara P; Halle-Hauss P; Bonhomme J; Travade P; Deméocq F
    Bone Marrow Transplant; 1997 Aug; 20(3):191-8. PubMed ID: 9257886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive selection of CD34+ cells from cryopreserved peripheral blood stem cells after thawing: technical aspects and clinical use.
    Bohbot A; Lioure B; Faradji A; Schmitt M; Cuillerot JM; Laplace A; Oberling F
    Bone Marrow Transplant; 1996 Feb; 17(2):259-64. PubMed ID: 8640176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and transplantation of highly purified autologous peripheral CD34+ progenitor cells: purging efficacy, hematopoietic reconstitution in non-Hodgkin's lymphoma (NHL): results of Japanese phase II study.
    Imai Y; Chou T; Tobinai K; Tanosaki R; Morishima Y; Ogura M; Shimazaki C; Taniwaki M; Hiraoka A; Tanimoto M; Koike T; Kogawa K; Hirai H; Yoshida T; Tamura K; Kishi K; Hotta T;
    Bone Marrow Transplant; 2005 Mar; 35(5):479-87. PubMed ID: 15654349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD34+ cell enrichment for autologous peripheral blood stem cell transplantation by use of the CliniMACs device.
    Després D; Flohr T; Uppenkamp M; Baldus M; Hoffmann M; Huber C; Derigs HG
    J Hematother Stem Cell Res; 2000 Aug; 9(4):557-64. PubMed ID: 10982256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of neuroblastoma cells in CD34+ selected peripheral stem cells using a combination of tyrosine hydroxylase nested RT-PCR and anti-ganglioside GD2 immunocytochemistry.
    Lode HN; Handgretinger R; Schuermann U; Seitz G; Klingebiel T; Niethammer D; Beck J
    Eur J Cancer; 1997 Oct; 33(12):2024-30. PubMed ID: 9516847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose therapy in multiple myeloma: effect of positive selection of CD34+ peripheral blood stem cells on hematologic engraftment and clinical outcome.
    Patriarca F; Damiani D; Fanin R; Grimaz S; Geromin A; Cerno M; Sperotto A; Silvestri F; Zaja F; Baccarani M
    Haematologica; 2000 Mar; 85(3):269-74. PubMed ID: 10702815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of immunomagnetic selection in purging autologous peripheral blood progenitor cell of breast cancer patients].
    Han X; Shi Y; Zhang W
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):203-6. PubMed ID: 11953162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and transplantation of highly purified autologous peripheral CD34+progenitor cells: purging efficacy, hematopoietic reconstitution following high dose chemotherapy in patients with breast cancer: results of a feasibility study in Japan.
    Chou T; Sano M; Ogura M; Morishima Y; Itagaki H; Tokuda Y
    Breast Cancer; 2005; 12(3):178-88. PubMed ID: 16110287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral blood stem cells: in vivo biology and therapeutic potential.
    Scheding S; Brugger W; Mertelsmann R; Kanz L
    Stem Cells; 1994; 12 Suppl 1():203-10; discussion 211. PubMed ID: 7535146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor cell depletion of peripheral blood progenitor cells using positive and positive/negative selection in metastatic breast cancer.
    Preti RA; Lazarus HM; Winter J; Stadtmauer EA; Nadasi S; McMannis J; Karandish S; Jennis A; Goldberg SL; Pecora AL
    Cytotherapy; 2001; 3(2):85-95. PubMed ID: 12028831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive selection of autologous peripheral blood stem cells.
    Lopez M; Beaujean F
    Baillieres Best Pract Res Clin Haematol; 1999; 12(1-2):71-86. PubMed ID: 11000984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.